Microbiota and the Gut-liver Axis: Bacterial Translocation, Inflammation and Infection in Cirrhosis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Dec 11

PMID 25492994

Citations 95

Authors

Valerio Giannelli

Vincenza Di Gregorio

Valerio Iebba

Michela Giusto

Serena Schippa

Manuela Merli

Ulrich Thalheimer

Affiliations

Soon will be listed here.

Abstract

Liver disease is associated with qualitative and quantitative changes in the intestinal microbiota. In cirrhotic patients the alteration in gut microbiota is characterized by an overgrowth of potentially pathogenic bacteria (i.e., gram negative species) and a decrease in autochthonous familiae. Here we summarize the available literature on the risk of gut dysbiosis in liver cirrhosis and its clinical consequences. We therefore described the features of the complex interaction between gut microbiota and cirrhotic host, the so called "gut-liver axis", with a particular attention to the acquired risk of bacterial translocation, systemic inflammation and the relationship with systemic infections in the cirrhotic patient. Such knowledge might help to develop novel and innovative strategies for the prevention and therapy of gut dysbiosis and its complication in liver cirrhosis.

Citing Articles

is associated with normal muscle mass and is related with sarcopenia in cirrhosis.

Efremova I, Alieva A, Maslennikov R, Poluektova E, Zharkova M, Kudryavtseva A Front Nutr. 2024; 11:1438897.

PMID: 39539377 PMC: 11557486. DOI: 10.3389/fnut.2024.1438897.

Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota.

Sun S, Zhang G, Lv S, Sun J Front Microbiol. 2024; 15:1407991.

PMID: 39234554 PMC: 11371771. DOI: 10.3389/fmicb.2024.1407991.

Editorial: The intricate web of gastrointestinal virome, mycome and archaeome: implications for gastrointestinal diseases.

Ahmad A, Ashfaq M, Rashid M Front Genet. 2024; 15:1463350.

PMID: 39184347 PMC: 11341467. DOI: 10.3389/fgene.2024.1463350.

Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective.

Baffy G, Portincasa P Metabolites. 2024; 14(6).

PMID: 38921459 PMC: 11205793. DOI: 10.3390/metabo14060324.

Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?.

Menzyk T, Skladany L, Adamcova-Selcanova S, Vnencakova J, Zilincanova D, Bystrianska N Clin Exp Hepatol. 2024; 9(4):344-350.

PMID: 38774193 PMC: 11103805. DOI: 10.5114/ceh.2023.132255.

References

Gupta N, Kumar A, Sharma P, Garg V, Sharma B, Sarin S . Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial. Liver Int. 2013; 33(8):1148-57. DOI: 10.1111/liv.12172. View

Begley M, Gahan C, Hill C . The interaction between bacteria and bile. FEMS Microbiol Rev. 2005; 29(4):625-51. DOI: 10.1016/j.femsre.2004.09.003. View

Thalheimer U, De Iorio F, Capra F, del Mar Lleo M, Zuliani V, Ghidini V . Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Eur J Gastroenterol Hepatol. 2010; 22(10):1228-34. DOI: 10.1097/MEG.0b013e32833b4b03. View

Seki E, De Minicis S, Osterreicher C, Kluwe J, Osawa Y, Brenner D . TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007; 13(11):1324-32. DOI: 10.1038/nm1663. View

Yamamoto M, Takeda K . Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract. 2011; 2010:240365. PMC: 3010626. DOI: 10.1155/2010/240365. View

Kaper J, Nataro J, Mobley H . Pathogenic Escherichia coli. Nat Rev Microbiol. 2004; 2(2):123-40. DOI: 10.1038/nrmicro818. View

Wiest R, Lawson M, Geuking M . Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2013; 60(1):197-209. DOI: 10.1016/j.jhep.2013.07.044. View

Simren M, Stotzer P . Use and abuse of hydrogen breath tests. Gut. 2006; 55(3):297-303. PMC: 1856094. DOI: 10.1136/gut.2005.075127. View

Riggio O, Varriale M, Testore G, Di Rosa R, Di Rosa E, Merli M . Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. J Clin Gastroenterol. 1990; 12(4):433-6. DOI: 10.1097/00004836-199008000-00016. View

10.

Bajaj J, Heuman D, Sanyal A, Hylemon P, Sterling R, Stravitz R . Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013; 8(4):e60042. PMC: 3615021. DOI: 10.1371/journal.pone.0060042. View

11.

Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D . Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011; 54(2):562-72. DOI: 10.1002/hep.24423. View

12.

Bauer T, Schwacha H, Steinbruckner B, Brinkmann F, Ditzen A, Aponte J . Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol. 2002; 97(9):2364-70. DOI: 10.1111/j.1572-0241.2002.05791.x. View

13.

Guarner C, Runyon B, Young S, Heck M, Sheikh M . Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol. 1997; 26(6):1372-8. DOI: 10.1016/s0168-8278(97)80474-6. View

14.

Li K, Bihan M, Methe B . Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One. 2013; 8(5):e63139. PMC: 3646044. DOI: 10.1371/journal.pone.0063139. View

15.

Rayes N, Seehofer D, Theruvath T, Schiller R, Langrehr J, Jonas S . Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant. 2005; 5(1):125-30. DOI: 10.1111/j.1600-6143.2004.00649.x. View

16.

Steffen E, Berg R . Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infect Immun. 1983; 39(3):1252-9. PMC: 348091. DOI: 10.1128/iai.39.3.1252-1259.1983. View

17.

Such J, Frances R, Munoz C, Zapater P, Casellas J, Cifuentes A . Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology. 2002; 36(1):135-41. DOI: 10.1053/jhep.2002.33715. View

18.

Morencos F, de las Heras Castano G, Martin Ramos L, Lopez Arias M, Ledesma F, Romero F . Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995; 40(6):1252-6. DOI: 10.1007/BF02065533. View

19.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D . Enterotypes of the human gut microbiome. Nature. 2011; 473(7346):174-80. PMC: 3728647. DOI: 10.1038/nature09944. View

20.

Perez-Cobas A, Gosalbes M, Friedrichs A, Knecht H, Artacho A, Eismann K . Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2012; 62(11):1591-601. PMC: 3812899. DOI: 10.1136/gutjnl-2012-303184. View